Considering implementing pharmacogenomics services into your practice? This course provides an overview of essential PGx terminology, the clinical utility of PGX, and guidance for developing a detailed testing process. In addition, learners will review and navigate key PGx sources to assist in assessing pharmacogenomic information and integrating it into clinical practice.

Upon successful completion of this knowledge-based course, pharmacists should be able to:
1. Define terminology used in pharmacogenomics (PGx)
2. Provide a review of the clinical relevance of PGx
3. Describe the PGx testing process
4. Identify various pharmacogenomics resources (e.g. FDA, CPIC, PharmGKB, PharmVar, AMP/CAP)
5. List the key components and steps required for the successful implementation of pharmacogenomics in clinical practice

Mary Malkin, PharmD
Postdoctoral Fellow
Allure Specialty Pharmacy

Dr. Malkin reports she is a postdoctoral Fellow with a joint program between Allure Specialty Pharmacy and Admera health. Admera Health provided funding for the development of this course.

CEimpact has taken appropriate action for conflict resolution, including additional peer review.

*CEimpact provides you with two (2) opportunities to complete the exam. If there are two failed attempts, the participant will not receive CPE credit.

Course fee includes the course, course materials, and CPE credit submission to CPE Monitor.
Initial Release Date: December 22, 2020
Planned Expiration Date: December 22, 2023